Manke Isaac's Form 4/A amendment
AmendedOnKure Therapeutics, Inc. (OKUR) · filed Aug 13, 2026
- Accession no.
- 0001622769-26-000006
- Filed
- Aug 13, 2026, 4:55 PM ET
- Rule 10b5-1 plan
- Not checked
- Original filed
- Aug 11, 2026
This filing lists no transactions.
This amendment replaces 0001622769-26-000002 (filed Aug 11, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Manke IsaacCIK 0001622769 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The original Form 4, filed August 11, 2026, reported the disposition on August 7, 2026 of an option to purchase 15,300 shares of Class A Common Stock (the "Disposition"), and a corresponding acquisition of an option to purchase 15,300 shares of Class A Common Stock (the "Acquisition"), each in connection with an Option Repricing, as defined in footnote 3 of the original Form 4. The Disposition and Acquisition did not occur.
- F2
1/36th of the shares subject to the option vested on November 4, 2024 and 1/36th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.